Resources
-
CMC Strategy Forum Japan 2025 Scientific Program
Scientific Program: CMC Strategy Forum Japan 2025
-
CMC Strategy Forum Japan 2025 Summary Infographic
Summary Infographic: CMC Strategy Forum Japan 2025
-
In-line Raman Spectroscopy for Process Characterization
Speaker Presentation: Netherlands Area Biotech Discussion Group 2025
Klijn Marieke, Delft University of Technology, 2025 -
Regulatory Expectations for Real-Time PAT and Continuous Manufacturing
Speaker Presentation: Netherlands Area Biotech Discussion Group 2025
Hoefnagel Marcel, Medicines Evaluation Board, 2025 -
A Practical Approach to Implementing ICH Q14: Tools for Analytical Quality by Design in Capillary Electrophoresis Method Development
Speaker Presentation: VEDG 2025
Van Tricht Ewoud, Sanger van de Griend Cari, Kantisto BV, 2025 -
PAT in Biopharmaceutical
Processes
Speaker Presentation: Netherlands Area Biotech Discussion Group 2025
Eppink Michel, Byondis BV, 2025 -
From Vulnerability to Resilience: Industry Strategies for Dealing with Critical Materials in Analytical Procedures
Speaker Presentation: VEDG 2025
Van Tricht Ewoud, Kantisto BV, 2025 -
Few Batches, Big Questions: Navigating AAV Analytical Comparability
Speaker Presentation: CGTP Europe 2025
Schermann Sonya, Ascend LTD, 2025 -
Genetic Engineering of Hematopoietic Cells: From Lentiviral Gene Replacement to Targeted Gene Editing
Speaker Presentation: CGTP Europe 2025
Naldini Luigi, San Raffaele Telethon Institute for Gene Therapy, 2025 -
Single-Cell Sequencing in Cell and Gene Therapy: Opportunities and Challenges for QC and Regulation
Speaker Presentation: CGTP Europe 2025
Muraro Mauro, Single Cell Discoveries BV, 2025 -
EMA Regulatory Update Rapid Fire Session
Speaker Presentation: CGTP Europe 2025
Session 6 Regulatory Panel, 2025 -
Biophysical Characterization and Control of AAV Using Multi-Attribute Methods
Speaker Presentation: CGTP Europe 2025
Hibbins Angus, Johnson & Johnson Innovative Medicine, 2025 -
Potency Assurance in Cell Therapy: Bridging Theory and Practice
Speaker Presentation: CGTP Europe 2025
Heemskerk Matthias, Galapagos NV, 2025 -
Adapting the Principles of Comparability Assessments for Complex ATMPs
Speaker Presentation: CGTP Europe 2025
Francissen Kathleen, Genentech, a Member of the Roche Group, 2025 -
Evaluating Sequencing Strategies for ATMP Genomic Risk Assessment
Speaker Presentation: CGTP Europe 2025
Buzatu Rafaella, Medicines Evaluation Board, 2025 -
Characterising Viral Vectors for Gene Therapy Delivery Using Mass Spectrometry on Different Levels
Speaker Presentation: CGTP Europe 2025
Bones Jonathan, NIBRT, 2025 -
CGTP Europe 2025 Summary Infographic
Summary Infographic: CGTP Europe 2025
-
CGTP Europe 2025 Scientific Program
Scientific Program: CGTP Europe 2025
-
Establishment of Robust Compendial Methods for Analysis of Monoclonal Antibody Products
Speaker Presentation: CMC Strategy Forum Europe 2025
Vesterinen Jaana, Finnish Medicines Agency, 2025 -
Reliance as an Essential Tool to Promote Efficient and Robust Global Regulatory Oversight
Speaker Presentation: CMC Strategy Forum Europe 2025
Valentin Marie, World Health Organization, 2025